Page 26 - Read Online

Ghosh et al. Plast Aesthet Res 2024;11:50 https://dx.doi.org/10.20517/2347-9264.2024.70 Page 11 of 11

77. Surgeons ASoP. Fat transfer/fat graft and fat injection: ASPS guiding principles. Available from: https://www.plasticsurgery.org/
Documents/Health-Policy/Principles/principle-2015-post-mastectomy-fat-grafting.pdf [Last accessed on 28 Sep 2024].
78. Tukiama R, Vieira RAC, Facina G, da Cunha Leal P, Zucca-Matthes G. Oncologic safety of autologous fat grafting after breast cancer
surgical treatment: a matched cohort study. Plast Reconstr Surg 2021;148:11-20. DOI PubMed
79. Cohen O, Lam G, Karp N, Choi M. Determining the oncologic safety of autologous fat grafting as a reconstructive modality: an
institutional review of breast cancer recurrence rates and surgical outcomes. Plast Reconstr Surg 2017;140:382e-92e. DOI PubMed
80. Hanson SE, Kapur SK, Garvey PB, et al. Oncologic safety and surveillance of autologous fat grafting following breast conservation
therapy. Plast Reconstr Surg 2020;146:215-25. DOI
81. Mestak O, Hromadkova V, Fajfrova M, Molitor M, Mestak J. Evaluation of oncological safety of fat grafting after breast-conserving
therapy: a prospective study. Ann Surg Oncol 2016;23:776-81. DOI PubMed
82. Goto H, Shimono Y, Funakoshi Y, et al. Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like
properties through adipsin. Oncogene 2019;38:767-79. DOI
83. Eterno V, Zambelli A, Pavesi L, et al. Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via
HGF/c-Met signaling. Oncotarget 2014;5:613-33. DOI PubMed PMC
84. Gehmert S, Gehmert S, Prantl L, Vykoukal J, Alt E, Song YH. Breast cancer cells attract the migration of adipose tissue-derived stem
cells via the PDGF-BB/PDGFR-beta signaling pathway. Biochem Biophys Res Commun 2010;398:601-5. DOI PubMed
85. Kuhbier JW, Bucan V, Reimers K, et al. Observed changes in the morphology and phenotype of breast cancer cells in direct co-culture
with adipose-derived stem cells. Plast Reconstr Surg 2014;134:414-23. DOI
86. Rowan BG, Gimble JM, Sheng M, et al. Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of
triple negative breast cancer xenografts. PLoS One 2014;9:e89595. DOI PubMed PMC
87. Orecchioni S, Gregato G, Martin-Padura I, et al. Complementary populations of human adipose CD34+ progenitor cells promote
growth, angiogenesis, and metastasis of breast cancer. Cancer Res 2013;73:5880-91. DOI
88. Charvet HJ, Orbay H, Wong MS, Sahar DE. The oncologic safety of breast fat grafting and contradictions between basic science and
clinical studies: a systematic review of the recent literature. Ann Plast Surg 2015;75:471-9. DOI PubMed
89. Calabrese C, Kothari A, Badylak S, et al. Oncological safety of stromal vascular fraction enriched fat grafting in two-stage breast
reconstruction after nipple sparing mastectomy: long-term results of a prospective study. Eur Rev Med Pharmacol Sci 2018;22:4768-
77. DOI PubMed
90. Mazur S, Zołocińska A, Siennicka K, Janik-Kosacka K, Chrapusta A, Pojda Z. Safety of adipose-derived cell (stromal vascular
fraction - SVF) augmentation for surgical breast reconstruction in cancer patients. Adv Clin Exp Med 2018;27:1085-90. DOI PubMed
91. Al Qurashi AA, Shah Mardan QNM, Alzahrani IA, et al. Efficacy of exclusive fat grafting for breast reconstruction: an updated
systematic review and meta-analysis. Aesthetic Plast Surg 2024. DOI
92. Administration USFaD. Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem
cell products in violation of the law. Available from: https://www.fda.gov/news-events/press-announcements/federal-court-issues-
decision-holding-us-stem-cell-clinics-and-owner-adulterated-and-misbranded-stem [Last accessed on 28 Sep 2024].
93. Services USDoHaH. Regulatory considerations for human cells, tissues, and cellular andtissue-based products: minimal manipulation
and homologous use. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/regulatory-
considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal [Last accessed on 28 Sep 2024].
94. Raposio E, Ciliberti R. Clinical use of adipose-derived stem cells: European legislative issues. Ann Med Surg (Lond) 2017;24:61-4.
DOI PubMed PMC
95. Bae YC, Song JS, Bae SH, Kim JH. Effects of human adipose-derived stem cells and stromal vascular fraction on cryopreserved fat
transfer. Dermatol Surg 2015;41:605-14. DOI PubMed
96. Zanata F, Bowles A, Frazier T, et al. Effect of cryopreservation on human adipose tissue and isolated stromal vascular fraction cells: in
vitro and in vivo analyses. Plast Reconstr Surg 2018;141:232e-43e. DOI
97. Zheng W, Shen J, Wang H, et al. Effects of frozen stromal vascular fraction on the survival of cryopreserved fat tissue. Aesthetic Plast
Surg 2019;43:826-35. DOI PubMed PMC